Reduction Mammaplasty for Breast-Related Symptoms
Customize your policy alerts
Sign up for Capital Bluecross Policy MP 1.013 alerts
Get alerted when Policy MP 1.013 changes without checking for updates manually.
Monitor payer policy activity
Governs medical necessity and coverage criteria for reduction mammaplasty (breast reduction) for macromastia and related symptoms across applicable Capital Bluecross products.
Removed breast pain, thoracic kyphosis, shoulder grooving, brachial plexus compression syndrome and congenital breast deformity from list of medically necessary indications for surgery.
Added the following ICD-10 codes to policy: G54.0; G56.40–G56.43; M40.04; M53.83; M54.2; M54.6; M95.4; N64.4; Q83.8.
Background and Rationale extensively revised; Policy Guidelines added/updated in the 03/06/2025 Minor Review.
Coverage Criteria
COVERAGE CRITERIA
Covered when ALL of the following are met:
Primary clinical criteria
- Symptom options: Chronic pain not responsive to conservative therapy OR recurrent/chronic intertrigo
- Supporting documentation: Photographs documenting breast size or shoulder grooving; documentation of planned/expected resection weight (commonly 500–600 g per breast) or use of the Schnur Sliding Scale; some protocols require member within 20% of ideal body weight.500-600 g; within 20% of ideal body weight
Schnur Sliding Scale may be used when resection weight would fall below 500–600 g
Reconstructive symmetry
Covered when ALL of the following are met:
Cites Act 51 of 1997 regarding reconstructive surgery coverage
Historic objective selection criteria
Policy history documents objective selection criteria that were used in prior iterations
Reflects prior criteria recorded in policy history; see full policy history for dates and prior wording.
Revised list of medically necessary indications (partial)
Changes to medically necessary indications
These indications were removed from the list of medically necessary indications in the 03/06/2025 Minor Review.
Updates to Medically Necessary Indications
Policy modifications to medically necessary indications
These items were removed from the policy's list of medically necessary indications during the 03/06/2025 Minor Review.
Medically Necessary Indications (revisions)
Policy statement unchanged by several reviews; however specific indications were removed in the 03/06/2025 minor review.
These were removed from the list of medically necessary indications for surgery (03/06/2025).
Revised medically necessary indications (partial)
Policy was updated; specific coverage criteria for medically necessary indications were revised by removing several indications and adding Policy Guidelines.
Described in 03/06/2025 Minor Review.
General coverage note
Policy statement unchanged; recent review removed several previously listed medically necessary indications and added Policy Guidelines.
Full coverage criteria are in the policy statement; review notes document removals and addition of Policy Guidelines.
Indications removed from medically necessary list
Following indications were removed from the list of medically necessary indications for breast reduction and therefore are not covered as medically necessary under this policy extract:
These indications were explicitly removed in the 03/06/2025 Minor Review.
Updated medically necessary indications
Policy review outcomes and indication changes
Providers must use the current policy indications when determining medical necessity.
Reduction mammaplasty is considered investigational for all indications not meeting the specified criteria in this policy because there is insufficient evidence to conclude benefit for other uses. The policy’s medically necessary indications are limited to well-documented macromastia with defined clinical symptoms (for example, a documented minimum 6-week history of shoulder/neck/back pain not responsive to conservative therapy or recurrent/chronic intertrigo) and reconstructive symmetry after mastectomy; procedures that do not meet those criteria fall into the investigational category.
Review notes from the 03/06/2025 Minor Review document removal of several previously listed indications from the medically necessary list (e.g., entries repeatedly note “Removed breast pain, thoracic kyphosis…”). These review-history lines indicate the policy text was updated on 03/06/2025 to remove certain indications and to revise Background/Rationale and Policy Guidelines.
The revision explicitly lists the following indications as removed from the list of medically necessary indications during the 03/06/2025 Minor Review: breast pain, thoracic kyphosis, shoulder grooving, brachial plexus compression syndrome, and congenital breast deformity.
Multiple review excerpts repeat that those indications were removed; the 03/06/2025 notes confirm removal and also state that Policy Guidelines were added in the same review cycle.
Summary language across the review history clarifies that the listed conditions are no longer included as medically necessary indications for reduction mammaplasty following the 03/06/2025 Minor Review and therefore should not be used alone to justify coverage.
Alternate fragments in the review history likewise record that breast pain, thoracic kyphosis, shoulder grooving, brachial plexus compression syndrome, and congenital breast deformity were removed from the medically necessary indications list and that Background and Rationale were extensively revised.
The available document fragment does not include a complete exclusions list, but it does explicitly show that several specific indications were removed from the medically necessary list in the 03/06/2025 update.
Multiple review entries across the document confirm the same set of removals (breast pain; thoracic kyphosis; shoulder grooving; brachial plexus compression syndrome; congenital breast deformity), reinforcing that these changes were applied consistently in the 03/06/2025 Minor Review.
The review-history lines reiterate removal of the same indications and note that Policy Guidelines were added, indicating the removals were part of an administrative minor review that also updated background material and references.
Contextual review notes repeat that those five indications were removed from the medically necessary indications list on 03/06/2025; the excerpts emphasize that the revision affected which indications are considered medically necessary rather than changing the core policy statement language otherwise.
Several chunks explicitly reference the removed conditions by name in the revision history, confirming the removals: breast pain; thoracic kyphosis; shoulder grooving; brachial plexus compression syndrome; congenital breast deformity were removed and the Policy Guidelines section was updated.
The implication of the repeated removal entries is that these conditions are effectively excluded from the policy’s medically necessary indications unless some other covered indication applies; the review notes instruct providers to refer to the current policy when determining medical necessity.
Recurrent references in the revision history restate that the listed conditions were removed and are no longer part of the medically necessary indications, indicating the change is applied consistently throughout the policy documentation.
The policy gives an example of the cosmetic exclusion approach: procedures performed for purely cosmetic reasons (for example, resection weight below the Schnur Sliding Scale 5th percentile or lacking documented functional symptoms) are considered not medically necessary.
The policy and its history make clear that subjective symptoms alone are insufficient to establish medical necessity; Plans use objective selection criteria (photographs, specified resection weight or Schnur Sliding Scale, and documentation of symptom duration and response to conservative therapy) to support coverage determinations.
The document explicitly notes that congenital breast deformity was removed from the medically necessary indications list during the 03/06/2025 Minor Review; Policy Guidelines for this condition were removed in that revision.
Throughout the revision notes, indications explicitly removed from the medically necessary list are presented as not medically necessary under this policy update unless they are addressed elsewhere in the full policy.
The repeated removal statements across the review history support the interpretation that the policy no longer recognizes these previously listed conditions as medically necessary indications for reduction mammaplasty.
Given the multiple explicit removal entries in the 03/06/2025 Minor Review notes, the removed conditions should be treated as not covered as medically necessary under this updated policy unless another, retained indication applies.
Alternate fragments of the review history repeat the removal language, again listing the same set of conditions removed from medically necessary status during the 03/06/2025 update.
The policy clarifies that procedures performed solely for the removed indications (for example, surgery performed solely for breast pain or shoulder grooving) are no longer considered medically necessary according to the updated policy excerpts.
Overall summary statements in the revision history capture that these five indications were removed from the medically necessary list in the 03/06/2025 Minor Review and are therefore no longer listed as medically necessary indications in the policy extract.
Additional chunks reiterate and confirm the removals, providing multiple redundant entries in the review history that the same indications were removed and that Policy Guidelines were added or revised in the same update.
Those review-history lines again restate the removals and the administrative updates (Background, Rationale, References, and added ICD-10 codes) associated with the 03/06/2025 Minor Review.
The review history consistently links the removal of these indications to the 03/06/2025 Minor Review and signals that providers should use the updated policy language and guidelines when documenting medical necessity.
Based on the repeated documentation in the revision history, the removed indications should be considered not medically necessary for policy purposes unless addressed elsewhere in the full policy document.
Coding and Diagnosis Codes
| 19318 | Reduction mammaplasty |
| L24.A0 | Irritant contact dermatitis due to friction or contact with body fluids, unspecified |
| L24.A9 | Irritant contact dermatitis due friction or contact with other specified body fluids |
| L30.4 | Erythema intertrigo |
| L98.44 | Non-pressure chronic ulcer of chest |
| L98.491 | Non-pressure chronic ulcer of skin of other sites limited to breakdown of skin |
| M25.511 | Pain in right shoulder |
| M25.512 | Pain in left shoulder |
| M25.519 | Pain in unspecified shoulder |
| M53.83 | Other specified dorsopathies, cervicothoracic region |
| M54.2 | Cervicalgia |
| G54.0 | Brachial plexus disorders |
| G56.40 | Unspecified mononeuropathy of upper limb |
| G56.41 | Carpal tunnel syndrome, right upper limb (example group member) |
| G56.42 | Carpal tunnel syndrome, left upper limb (as part of listed series) |
| G56.43 | Carpal tunnel syndrome, bilateral upper limbs (as part of listed series) |
| M40.04 | Thoracic kyphosis (example code listed) |
| M53.83 | Other specified thoracic, thoracolumbar and lumbosacral intervertebral disc disorders |
| M54.2 | Cervicalgia |
| M54.6 | Pain in thoracic spine |
| M95.4 | Scar conditions and fibrosis of breast |
| G54.0 | |
| G56.40 | |
| G56.41 | |
| G56.42 | |
| G56.43 | |
| M40.04 | |
| M53.83 | |
| M54.2 | |
| M54.6 | |
| M95.4 |
| G54.0 | Exact ICD-10 code added to policy |
| G56.40 | Exact ICD-10 code added to policy |
| G56.41 | Exact ICD-10 code added to policy |
| G56.42 | Exact ICD-10 code added to policy |
| G56.43 | Exact ICD-10 code added to policy |
| M40.04 | Exact ICD-10 code added to policy |
| M53.83 | Exact ICD-10 code added to policy |
| M54.2 | Exact ICD-10 code added to policy |
| M54.6 | Exact ICD-10 code added to policy |
| M95.4 | Exact ICD-10 code added to policy |
| G54.0 | listed in policy |
| G56.40 | listed in policy |
| G56.41 | listed in policy |
| G56.42 | listed in policy |
| G56.43 | listed in policy |
| M40.04 | listed in policy |
| M53.83 | listed in policy |
| M54.2 | listed in policy |
| M54.6 | listed in policy |
| M95.4 | listed in policy |
| G54.0 | ICD-10 code added to policy |
| G56.40 | ICD-10 code added to policy |
| G56.41 | ICD-10 code added to policy |
| G56.42 | ICD-10 code added to policy |
| G56.43 | ICD-10 code added to policy |
| M40.04 | ICD-10 code added to policy |
| M53.83 | ICD-10 code added to policy |
| M54.2 | ICD-10 code added to policy |
| M54.6 | ICD-10 code added to policy |
| M95.4 | ICD-10 code added to policy |
| G54.0 | Exact code added to policy |
| G56.40 | Exact code added to policy |
| G56.41 | Exact code added to policy |
| G56.42 | Exact code added to policy |
| G56.43 | Exact code added to policy |
| M40.04 | Exact code added to policy |
| M53.83 | Exact code added to policy |
| M54.2 | Exact code added to policy |
| M54.6 | Exact code added to policy |
| M95.4 | Exact code added to policy |
| G54.0 | exact description from document |
| G56.40 | exact description from document |
| G56.41 | exact description from document |
| G56.42 | exact description from document |
| G56.43 | exact description from document |
| M40.04 | exact description from document |
| M53.83 | exact description from document |
| M54.2 | exact description from document |
| M54.6 | exact description from document |
| M95.4 | exact description from document |
| G54.0 | |
| G56.40 | |
| G56.41 | |
| G56.42 | |
| G56.43 | |
| M40.04 | |
| M53.83 | |
| M54.2 | |
| M54.6 | |
| M95.4 |
| G54.0 | |
| G56.40 | |
| G56.41 | |
| G56.42 | |
| G56.43 | |
| M40.04 | |
| M53.83 | |
| M54.2 | |
| M54.6 | |
| M95.4 |
| G54.0 | |
| G56.40 | |
| G56.41 | |
| G56.42 | |
| G56.43 | |
| M40.04 | |
| M53.83 | |
| M54.2 | |
| M54.6 | |
| M95.4 |
| G54.0 | Exact code added to policy (description not provided in excerpt) |
| G56.40 | Exact code added to policy (description not provided in excerpt) |
| G56.41 | Exact code added to policy (description not provided in excerpt) |
| G56.42 | Exact code added to policy (description not provided in excerpt) |
| G56.43 | Exact code added to policy (description not provided in excerpt) |
| M40.04 | Exact code added to policy (description not provided in excerpt) |
| M53.83 | Exact code added to policy (description not provided in excerpt) |
| M54.2 | Exact code added to policy (description not provided in excerpt) |
| M54.6 | Exact code added to policy (description not provided in excerpt) |
| M95.4 | Exact code added to policy (description not provided in excerpt) |
| G54.0 | exact code added as listed |
| G56.40 | exact code added as listed |
| G56.41 | exact code added as listed |
| G56.42 | exact code added as listed |
| G56.43 | exact code added as listed |
| M40.04 | exact code added as listed |
| M53.83 | exact code added as listed |
| M54.2 | exact code added as listed |
| M54.6 | exact code added as listed |
| M95.4 | exact code added as listed |
Provider Actions and Authorization
Prior authorization required; include CPT 19318
Prior authorization is required per Capital Blue Cross program/product rules; include the reduction mammaplasty CPT procedure code 19318 on prior authorization submissions for surgical services governed by this policy.
- Procedure code listed: 19318
Use objective selection criteria with PA requests
Prior authorization decisions reference objective selection criteria — submit photographic evidence of breast size or shoulder grooving, documentation of planned/expected resection weight (commonly 500–600 g per breast or per Schnur Sliding Scale), and weight relative to ideal body weight when applicable.
- Photographs documenting breast size or shoulder grooving
- Planned/expected resection weight (commonly 500–600 g per breast) or Schnur Sliding Scale
- Requirement to be within 20% of ideal body weight (when used)
Include newly added ICD‑10 codes on authorization requests
Use the ICD‑10 diagnosis codes that were added to the policy when requesting authorization; include one or more listed diagnoses to support medical necessity.
- Examples of added codes: G54.0; G56.40–G56.43; M40.04; M53.83; M54.2; M54.6; M95.4; N64.4; Q83.8
Cite updated policy (effective 2025‑10‑01) and diagnoses
Reference the updated policy (effective 2025‑10‑01) and ensure authorization submissions include diagnoses consistent with the policy’s newly added ICD‑10 codes and updated Background/Policy Guidelines.
- Policy effective date: 2025-10-01
- Use updated Background/Rationale and Policy Guidelines when preparing PA documentation
Revise PAs to reflect 03/06/2025 removals and added ICD‑10 codes
After the 03/06/2025 Minor Review removed several indications and appended ICD‑10 codes, update prior authorization requests to reflect those removed indications and to use the policy’s added diagnosis codes.
- Removed indications include: breast pain; thoracic kyphosis; shoulder grooving; brachial plexus compression syndrome; congenital breast deformity
- Added ICD‑10 codes must be used where applicable
Include updated diagnosis codes on PA submissions
When submitting prior authorization, cite the appropriate ICD‑10 diagnosis codes added to the policy to support the indication for surgery.
- Required codes to reference include (as applicable): G54.0; G56.40; G56.41; G56.42; G56.43; M40.04; M53.83; M54.2; M54.6; M95.4; N64.4; Q83.8
Confirm indications and ICD‑10 codes before PA
Verify current medically necessary indications and the policy’s ICD‑10 code list before submitting prior authorization because recent revisions may affect coverage determinations.
- Confirm that removed indications are not being used as the sole justification for surgery
- Confirm which ICD‑10 codes apply to the member’s condition prior to PA submission
Ensure PA reflects updated indications (post‑03/06/2025)
Prior authorization determinations must follow the updated medically necessary indications after the 03/06/2025 removals; do not rely on indications that were removed when requesting authorization.
- Removed indications are not listed as medically necessary after 03/06/2025
- PA requests relying solely on removed indications may not meet criteria
Follow existing PA process but use updated references
Existing prior authorization processes remain operative, but providers must reference the updated policy language, added ICD‑10 codes, and Policy Guidelines when preparing submissions.
- Follow insurer’s standard PA submission requirements
- Include updated policy references and diagnosis codes
Add listed ICD‑10 codes to PA and documentation as applicable
The policy added multiple ICD‑10 codes to its coding list (see policy); include those newly added codes in documentation and authorization where applicable.
- Added codes include: G54.0; G56.40–G56.43; M40.04; M53.83; M54.2; M54.6; M95.4; N64.4; Q83.8
Provide supporting documentation per updated Policy Guidelines
Submit supporting documentation consistent with updated Policy Guidelines — include symptom history, conservative therapy attempts, photographs, and resection weight documentation as required by the revised guidance.
- Document minimum 6‑week symptom duration and failure of conservative therapy
- Provide photographs and planned/expected resection weight (commonly ≥500–600 g per breast or per Schnur)
- Follow the new Policy Guidelines in the full policy for additional documentation expectations
PA submission must comply with updated policy guidelines
Submit prior authorization consistent with the updated policy guidelines; prior authorization is required for surgical services governed by this medical policy.
- PA governed by Capital Blue Cross administrative processes for surgical services under this policy
- Follow updated Policy Guidelines when requesting authorization
Prior authorization required for surgical services under this policy
Prior authorization is required for reduction mammaplasty per Capital Blue Cross administrative rules; follow the insurer’s standard PA submission process for surgical services under this policy.
- PA requirement applies to programs/products administered by Capital Blue Cross
Document failed conservative therapy before PA
Require and document prior conservative therapy attempts (support bra, exercises, heat/cold, NSAIDs or muscle relaxants) and their failure before seeking authorization for surgery.
- Conservative therapies must be attempted and documented
- Examples: appropriate support bra, exercises, heat/cold, NSAIDs, muscle relaxants
Required documentation: symptom duration, conservative therapy, photos, resection weight
Document minimum symptom duration (at least 6 weeks), failure of conservative therapy, photographic evidence (breast size/shoulder grooving), and planned/actual resection weight (commonly 500–600 g per breast or per Schnur Sliding Scale) to support medical necessity.
- Minimum documented symptom duration: 6 weeks
- Photographs documenting breast size or shoulder grooving
- Planned/expected or actual resection weight (commonly 500–600 g per breast; Schnur may be used)
Include photographs, resection weight, and causation evidence in documentation
Photographic documentation, resection weight (or Schnur Sliding Scale), and evidence that macromastia is the primary cause of symptoms should be included in the record and PA submission to meet selection criteria.
- Photographs documenting shoulder grooving or breast size
- Planned/expected resection weight or Schnur Sliding Scale calculation
- Evidence macromastia is primary cause of symptoms
Use added ICD‑10 codes in documentation and claims
Use the policy’s added ICD‑10 codes to support diagnosis coding on claims and authorization requests (examples include G54.0, G56.40–G56.43, M40.04, M53.83, M54.2, M54.6, M95.4, N64.4, Q83.8).
- Include one or more of the policy-listed ICD‑10 codes when applicable to the clinical presentation
Align documentation with new Policy Guidelines and Background/Rationale
Ensure documentation aligns with the Policy Guidelines added in the 03/06/2025 Minor Review and with the Background/Rationale updates when requesting authorization.
- Consult the Policy Guidelines section in the full policy for specific documentation expectations
- Align documentation with updated Background and Rationale
Denial risk if required documentation is missing
Requests lacking required documentation (minimum 6‑week symptom history, failed conservative therapy, photographs, or resection weight/Schnur evidence) may be denied as not meeting medical necessity.
- Denial trigger: insufficient symptom duration or lack of documented conservative therapy failure
- Denial trigger: absence of photographic evidence or resection weight documentation
Selection criteria (photos, weight, Schnur, BMI) can trigger denial
Plans may use objective selection criteria (photographs, minimum resection weight commonly 500–600 g per breast, Schnur Sliding Scale, or being within 20% of ideal body weight); failure to meet these criteria can trigger coverage denial.
- Common minimum resection weight cited: 500–600 g per breast
- Schnur Sliding Scale used when resection weight <500–600 g
- Some protocols require patient within 20% of ideal body weight
Denial risk if relying on removed indications
Claims or prior authorization requests based solely on indications that were removed from the medically necessary list (breast pain; thoracic kyphosis; shoulder grooving; brachial plexus compression syndrome; congenital breast deformity) may be denied.
- Removed indications (03/06/2025): breast pain; thoracic kyphosis; shoulder grooving; brachial plexus compression syndrome; congenital breast deformity
- Do not submit PA relying only on these removed indications
Increased denial risk when removed indications are used
Removal of specific indications from the medically necessary list increases the risk of denial when those indications are cited as the primary justification for surgery.
- Providers should not cite removed indications as sole justification
- Verify current medically necessary indications before scheduling surgery or submitting a PA
Requests citing removed indications risk denial after 03/06/2025
Claims or PA requests referencing previously listed indications removed in the 03/06/2025 minor review may not meet the policy’s medically necessary indications and could be denied.
- Removed indications were explicitly listed in the 03/06/2025 Minor Review
- Requests referencing those indications may be subject to denial
Risk of not‑medically‑necessary determination when removed indications are used
If a procedure is performed for an indication removed from the medically necessary list, the claim may be considered not medically necessary — verify covered indications prior to performing surgery.
- Removed indications are no longer listed as medically necessary per the Minor Review
- Confirm covered indications to avoid post‑service denials
Background and Rationale
Background: Macromastia (gigantomastia) is breast hyperplasia or hypertrophy associated with symptoms such as shoulder, neck, or back pain and recurrent intertrigo. Reduction mammaplasty removes breast tissue to relieve physical symptoms and/or psychosocial distress; evidence supports improvement in symptoms and functional limitations with acceptable complication rates, and the policy lists specific medically necessary indications and documentation expectations for coverage.
Definitions
Revision History
Removed breast pain, thoracic kyphosis, shoulder grooving, brachial plexus compression syndrome and congenital breast deformity from the list of medically necessary indications; Policy Guidelines removed/added and Background/Rationale and References extensively revised.
Policy document updated with changes reflected as effective 2025-10-01 (see Minor Review dated 03/06/2025 for content changes).
Updated policy effective date noted as 2025-10-01; ICD-10 codes were appended to the policy (G54.0; G56.40–G56.43; M40.04; M53.83; M54.2; M54.6; M95.4; N64.4; Q83.8).
Consensus review with background/references updates and cross-referenced policies updated; no change to policy statement recorded.
Consensus review recorded with background and references updated; no change to policy statement.
Confirmed removal of specified medically necessary indications (breast pain; thoracic kyphosis; shoulder grooving; brachial plexus compression syndrome; congenital breast deformity) and addition/removal of Policy Guidelines across review notes.
Background and references extensively revised and updated; consensus review noted with no change to policy statement.
Prior consensus review recorded (no change to policy statement); background and references updated.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.